Table 5.

Pathological stage in the untreated and treated patients with clinical stage B disease

Pathological stage	Surgery only (%)	12 weeks of NHT (%)	24 weeks of NHT (%)
B	40 (40.4%)	59 (54.6%)	59 (64.8%)
C1	45 (45.5%)	33 (30.6%)	23 (25.3%)
C2	9 (9.1%)	11 (10.2%)	7 (7.7%)
D1	5 (5.0%)	5 (4.6%)	2 (2.2%)
Total	99	108	91

Chi square=13.124; p=0.041. Untreated versus 12 weeks of NHT: χ²=5.311; p=0.199 (not significant (NS)). Untreated versus 24 weeks of NHT: χ²=11.984; p=0.009. 12 weeks of NHT versus 24 weeks of NHT: χ²=2.526; p=0.641 (NS).

NHT, neoadjuvant hormonal treatment.